Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study-Reference-Cited by-同舟云学术

Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study

Published:2016-12 Issue: Volume:30 Page:136-140
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Barroso-Sousa Romualdo,Paes Flavia Rocha,Vaz-Luis Ines,Batista Rafael Borges,Costa Rafael Brant,Losk Katya,Camuso Kristen,Metzger-Filho Otto,Hughes Melissa E.,Bunnell Craig A.,Golshan Mehra,Winer Eric P.,Lin Nancy U.

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference23 articles.

1. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer;Edwards;Cancer,2014

2. Effect of screening and adjuvant therapy on mortality from breast cancer;Berry;N Engl J Med,2005

3. Breast cancer statistics, 2015: convergence of incidence rates between black and white women;DeSantis;CA a Cancer J Clin,2016

4. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials;Peto;Lancet,2012

5. The development of dose-dense adjuvant chemotherapy;Hudis;Breast J,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis;Breast Cancer;2021-06-09

2. Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study;Journal of Clinical Oncology;2020-07-20

3. Reply to Garcia J. et al.;The Breast;2017-08